Rosenblatt David MD entered the industry of Internal Medicine Doctors in 0 and has grown to employ 1 to 4 people, generating an annual revenue of $500.000 to $999.999. The NAICS classifies this business under the code 6211110, which describes it as a Internal Medicine Doctors. For further clarification, the SIC classifies this business under the code 8011 and described it as a Internal Medicine Doctors. The business provides service to the B2C market.
To acquire more information, please contact David Rosenblatt by calling (410) 278-1718 during business hours. You can also write to the business’ Single Location at 2501 Oakington St, Aberdeen Proving Ground, Maryland MD 21005. You can also visit the company’s website at . View this business’ social media profiles on Twitter or on Facebbok .
Company: | Rosenblatt David MD |
Representative: | David Rosenblatt |
Place of Business: | 2501 Oakington St, Aberdeen Proving Ground, MD 21005 |
Contact Number: | (410) 278-1718 |
Type of Service: | Internal Medicine Doctors |
SIC Number: | 8011 |
NAICS Number: | 6211110 |
Locality: | Single Location |
Market Type: | B2C (Business to Consumer) |
Income/Year: | $500.000 to $999.999 |
Laborers: | 1 to 4 |
Share This Company: |
Rosenblatt David MD is a company operating from Harford, Maryland providing professional Internal Medicine Doctors and relevant B2C variables. It was founded in 0 and registered with the SIC code 8011 as Internal Medicine Doctors, and with the NAICS code 6211110 as Internal Medicine Doctors.
With a current employee count of 1 to 4, Rosenblatt David MD has gone to report making $500.000 to $999.999 per annum on its journey towards growth. This company invites you to contact its representative David Rosenblatt at (410) 278-1718 for related queries, or to locate its Single Location using the coordinates 39.48617,-76.13769.
The Single Location can also be found at the street address 2501 Oakington St in Aberdeen Proving Ground, Maryland 21005 and can be engaged online through the company website at , the company Twitter , and Facebook page .